FDA Adverse Event Injury Summary report: N

EVOKE CLOSED LOOP STIMULATOR (CLS)

MDR report key: 24530978 · Received March 6, 2026

Report

Report Number
3021836309-2026-00063
Event Type
Injury
Date Received
March 6, 2026
Date of Event
February 11, 2026
Report Date
March 6, 2026
Manufacturer
SALUDA MEDICAL PTY LTD
Product Code
LGW
PMA / PMN Number
P190002
Adverse Event
Yes
Report Source
Manufacturer report
Reporter Location
AU
Reporter Occupation
PHYSICIAN
Health Professional
Yes

Narratives

Additional Manufacturer Narrative · 0

THE EVOKE SCS SYSTEM WAS RETURNED TO SALUDA. THE CLS PASSED FUNCTIONAL TESTING WITH NO ANOMALIES IDENTIFIED. THE LEADS COULD NOT BE TESTED DUE TO DAMAGE SUSTAINED DURING EXPLANT. THE MANUFACTURING RECORDS OF THE LEADS WERE REVIEWED, AND THE PRODUCT MET ALL REQUIREMENTS FOR RELEASE. THE ROOT CAUSE OF THE DISCONNECTED ELECTRODES COULD NOT BE DEFINITIVELY DETERMINED. THE PATIENT REQUESTED EXPLANT OF THEIR EVOKE SCS SYSTEM DUE TO CHALLENGES OPERATING THE DEVICE. FIRST LEAD INFORMATION: BRAND NAME: EVOKE 12C PERCUTANEOUS LEAD KIT - 60CM. MODEL: 103807. CATALOG: 1008. LOT/BATCH NUMBER: 9017015025. UDI: (B)(4). MANUFACTURE DATE: 28 FEBRUARY 2024. EXPIRATION DATE: 27 FEBRUARY 2025. SECOND LEAD INFORMATION: SAME AS FIRST LEAD.

Description of Event or Problem · 0

A PATIENT IMPLANTED WITH AN EVOKE SPINAL CORD STIMULATION (SCS) SYSTEM REQUESTED A SYSTEM EXPLANT. THE PATIENT STATED THAT THEY WERE UNABLE TO OPERATE THE DEVICE DUE TO THEIR AGE AND HAD CHOSEN TO FOCUS ON OTHER HEALTH ISSUES AND ELECTED TO TURN OFF THE EVOKE SCS SYSTEM. THE PATIENT REQUIRED A MAGNETIC RESONANCE IMAGING (MRI) SCAN FOR EVALUATION OF OTHER HEALTH ISSUES; HOWEVER, DISCONNECTED ELECTRODES WERE OBSERVED ON BOTH LEADS DURING THE PERMANENT IMPLANT PROCEDURE OF EVOKE SCS SYSTEM, RENDERING THE SYSTEM¿S MRI COMPATIBILITY. SUBSEQUENTLY, THE EVOKE SCS SYSTEM WAS EXPLANTED.

Devices

Seq Brand Generic Product Code Manufacturer Model Lot UDI-DI
596403 EVOKE CLOSED LOOP STIMULATOR (CLS) SCS IPG LGW SALUDA MEDICAL PTY LTD 100667

Patients

Seq Age Sex Outcome Treatment
1 NA Female Other